09.21.22 -- The Changing Landscape Of Oncology Drug Development

This white paper provides strategic guidance for successfully navigating complexities, focusing specifically on unique formulation and handling requirements, novel trial designs and supply chain implications, and regulatory and clinical strategies to support product approvals.

Fully understanding the risks through ongoing data collection and analysis is essential. Discover how classifying exposure limits for a given substance enables manufacturers to identify and implement the best control strategy to protect operators and drug products to reliably and consistently ensure worker and patient safety.

Through the strategic selection of excipients, coatings, and delivery technologies, developers can alter and adjust such features as palatability and swallowability while optimizing dosing, bioavailability, release mechanisms, and other performance attributes. Gain insight into the systematic application of patient centricity to the design of OSD products.